Ian Clark - Genentech
Ian Clark is chief executive officer, Genentech, a member of the Roche Group, and head of North American Commercial Operations. He was appointed to this role in January of 2010. He also leads the Genentech Executive Committee and is a member of the Genentech Board of Directors.
Clark joined Genentech in 2003 as senior vice president and general manager, BioOncology. In August 2005 he was named senior vice president, Commercial Operations and became a member of the Executive Committee, and in January 2006, he was named executive vice president, Commercial Operations. In this role, he was responsible for leading all of Genentech’s Commercial functions including Sales, Marketing, Managed Care, Customer Operations and Commercial Operations Support. He was named head of Global Product Strategy and chief marketing officer in April 2009.
Prior to joining Genentech, Clark served as president of Novartis Canada, overseeing all of the company’s country operations. Before assuming his post in Canada, Clark served as chief operating officer for Novartis United Kingdom. Prior to joining Novartis in 1999, Clark worked in vice presidential roles in sales and marketing for Sanofi (Aventis) and Ivax in the United Kingdom and Eastern Europe. Clark started his career at Searle, where he held management positions in both sales and marketing.
Clark is a member of the Board of Directors of Solazyme Inc., a renewable oil and bioproducts company. He previously served on the corporate boards of Vernalis plc and Dendreon Corporation, both publicly traded biopharmaceutical companies. Clark currently serves on the Board of the Biotechnology Industry Organization (BIO) Industry Association (2009), the Technology Network Executive Council (2010), the Federal Reserve Bank of San Francisco’s Economic Advisory Council (2012), and is an advisor to the Institute of Life Sciences at Southampton University in the United Kingdom.
Clark received a Bachelor of Science degree in biological sciences from Southampton University in the United Kingdom.